ARCHIVES

First Compound From New In Vitro Screening to Enter Clinical Trials

This article is from The Cancer Letter archive.

Vol. 12 No. 47 | December 5, 1986

Download PDF Visit The Full Archive

Related Articles

MSK Withdraws Form Breast Cancer Nutrition Study Over Chemotherapy Issue; Program Still “Going Well”

June 21, 1985

Alan Rabson Named Acting NCI Director

October 5, 2001

NCAB Committee Submits Drafts Of QRA Policy Statement

July 8, 1983

Society Develops Guidelines For Integrative Oncology

August 31, 2007

Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study

December 26, 2014

Budesonide Not Beneficial For Diarrhea In Melanoma

August 28, 2009